Investor mix
13 investors on record; lead investors include Shenzhen Capital Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 31% |
| Private equity | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 7 | 54% |
CDMO focused on manufacturing of cell & gene therapy services
13 investors on record; lead investors include Shenzhen Capital Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 31% |
| Private equity | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 7 | 54% |